Heather Rae Hufnagel

This inventor holds 11 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignees: Janssen Pharmaceutica Nv, 3-Dimensional Pharmaceuticals, Inc.. Active years: 2006-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heather Rae Hufnagel. Retrieved from https://idiyas.com/inventor/heather-rae-hufnagel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 45.5

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 7.7

ph-index = 5

Forward Citations = 79(Granted Patents)

Company Filing History:

8 out of 2,101

Janssen Pharmaceutica Nv

patents

3 out of 77

3-Dimensional Pharmaceuticals, Inc.

patents

Years Active: 2006-2013

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8513229 - 4-Azetidinyl-1-phenyl-cyclohexane antagonists of CCR2 (2013-08-20),

2. 8450304 - 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of CCR2 (2013-05-28),

3. 8324186 - 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of CCR2 (2012-12-04),

4. 8269015 - 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of CCR2 (2012-09-18),

5. 8173654 - Triazolopyridazine compounds (2012-05-08),

6. 8030305 - Triazolopyridazines as kinase modulators (2011-10-04),

7. 7868023 - Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions (2011-01-11),

8. 7482376 - Conjugated complement cascade inhibitors (2009-01-27),

9. 7385066 - Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions (2008-06-10),

10. 7138530 - Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions (2006-11-21),

11. 7109354 - Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions (2006-09-19),

Title: The Innovative Contributions of Heather Rae Hufnagel

Introduction

Heather Rae Hufnagel is a prominent inventor based in Glenmoore, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various health conditions. With a total of 11 patents to her name, Hufnagel's work has the potential to impact the treatment of serious diseases.

Latest Patents

Among her latest patents are two notable inventions. The first is titled "4-Azetidinyl-1-phenyl-cyclohexane antagonists of CCR2." This invention comprises compounds of Formula (I), which are designed to prevent, treat, or ameliorate conditions such as type II diabetes, obesity, and asthma. The method involves inhibiting CCR2 activity in mammals through the administration of a therapeutically effective amount of the compounds. The second patent is "4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of CCR2." Similar to the first, this invention includes pharmaceutical compositions that aim to address CCR2 mediated syndromes, disorders, or diseases.

Career Highlights

Hufnagel has worked with reputable companies in the pharmaceutical industry, including Janssen Pharmaceutica NV and 3-Dimensional Pharmaceuticals, Inc. Her experience in these organizations has contributed to her expertise in drug development and innovation.

Collaborations

Throughout her career, Hufnagel has collaborated with notable professionals in her field, including Ehab Khalil and Kristi A. Leonard. These collaborations have likely enhanced her research and development efforts.

Conclusion

Heather Rae Hufnagel's innovative work in pharmaceuticals demonstrates her commitment to advancing medical science. Her patents reflect her dedication to finding solutions for complex health issues.

Profile summary based on public USPTO records.